How is the Jasper Therapeutics Inc today?

The Jasper Therapeutics Inc today is trading in the down by -4.37% at 4.82.

What is Jasper Therapeutics Inc Annual Net Profit?

Jasper Therapeutics Inc Annual Net Profit fell 10.55% in the last year to $71.27 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Jasper Therapeutics Inc Price to Earning Ratio?

Jasper Therapeutics Inc Price to Earning Ratio is -0.92, which is negative.

What is Jasper Therapeutics Inc Stock Price?

Jasper Therapeutics Inc Stock Price fell 79.25% and underperformed its sector by 90.58% in the past year.

What is Jasper Therapeutics Inc Quarterly Net profit?

Jasper Therapeutics Inc Quarterly Net profit fell 54.73% YoY to $21.24 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Jasper Therapeutics Inc Debt to Equity Ratio?

Jasper Therapeutics Inc Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Jasper Therapeutics Inc Return on Equity(ROE)?

Jasper Therapeutics Inc Return on Equity(ROE) for the last financial year was -101.73%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Jasper Therapeutics Inc Mutual Fund Holding?

Jasper Therapeutics Inc Mutual Fund Holding decreased by 1.48% in the last quarter to 24.52.

What is Jasper Therapeutics Inc Institutional Holding?

Jasper Therapeutics Inc Institutional Holding decreased by 18.38% in the last quarter to 96.18.

Jasper Therapeutics Inc XNAS: JSPR

Jasper Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Jasper Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Jasper Therapeutics Inc
Rating: 1.15025
Author: Trendlyne DVM scores

about

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cel...

4.82 -0.22 (-4.37%)

82.04% Fall from 52W High

191.4K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

10.0 / 100

Technically Neutral

36.0 / 100

No estimates available

Jasper Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Jasper Therapeutics Inc FAQ

How is Jasper Therapeutics Inc today?

Jasper Therapeutics Inc today is trading in the red, and is down by -4.37% at 4.82.

How has Jasper Therapeutics Inc performed historically?

Jasper Therapeutics Inc is currently trading down -4.37% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -21.75% in the past quarter and fell -79.25% in the past year. You can view this in the overview section.